25th Jul 2007 12:03
Proteome Sciences Plc ("Proteome Sciences" or "the Company")
DIRECTOR'S DEALING
Proteome Sciences announces that it has received notification today from James Malthouse, an Executive Director of the Company, that 50,000 ordinary shares that were held in his late wife's name have been transferred for a nil consideration to his adult daughter. As a consequence of this, the shares no longer form part of his beneficial holdings as defined by the AIM rules.
James Malthouse now has an interest in 250,000 Ordinary Shares of the issued ordinary share capital of the Company.
Enquiries Proteome Sciences plc
Christopher Pearce, Chief Executive Officer
Email: [email protected]
James Malthouse, Finance Director
Email: [email protected]
Tel: +44 (0)1932 865065
Public Relations for Proteome Sciences
IKON AssociatesAdrian Shaw Tel: +44 (0)1483 535102Mobile: +44 (0)797 9900733Email: [email protected] Coast CommunicationsMatt BaldwinTel: +44 (0) 1233 503200Mobile: +44 (0) 7930 439739
Email: [email protected]
PROTEOME SCIENCES PLCRelated Shares:
Proteome